Compare Resource Alam Indonesia Tbk (KKGI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Resource Alam Indonesia Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Resource Alam Indonesia Tbk trades at Rp302 (market cap 1.51T, 2.44M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Resource Alam Indonesia Tbk is far larger — about 14.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KKGI | SCPI | |
|---|---|---|
Market Cap | 1.51T | 104.4B |
Volume | 2.44M | — |
Lot | 24.4K | — |
Turnover | 733.28M | — |
Average Price | 300.5 | — |
Value | 733.28M | — |
Indicative Equilibrium Price | 302 | — |
Indicative Equilibrium Volume | 5 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Resource Alam Indonesia Tbk
PT Resource Alam Indonesia Tbk (the Company) was originally established under the name PT Kurnia Kapuas Utama Glue Industries (which was subsequently changed to PT Kurnia Kapuas Utama Tbk). PT Kurnia Kapuas Glue industries founded in 1981 in Pontianak, West Kalimantan and produces formalin and resin. The company supplies glue for plywood factories within the Bumi Raya Utama Group (BRU Group). The company is domestic investment.
Read more on KKGI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
